Literature DB >> 22687196

Quantification and minimization of uncertainties of internal target volume for stereotactic body radiation therapy of lung cancer.

Hong Ge1, Jing Cai, Chris R Kelsey, Fang-Fang Yin.   

Abstract

PURPOSE: To quantify uncertainties in delineating an internal target volume (ITV) and to understand how these uncertainties may be individually minimized for stereotactic body radiation therapy (SBRT) of early stage non-small cell lung cancer (NSCLC). METHODS AND MATERIALS: Twenty patients with NSCLC who were undergoing SBRT were imaged with free-breathing 3-dimensional computed tomography (3DCT) and 10-phase 4-dimensional CT (4DCT) for delineating gross tumor volume (GTV)(3D) and ITV(10Phase) (ITV3). The maximum intensity projection (MIP) CT was also calculated from 10-phase 4DCT for contouring ITV(MIP) (ITV1). Then, ITV(COMB) (ITV2), ITV(10Phase+GTV3D) (ITV4), and ITV(10Phase+ITVCOMB) (ITV5) were generated by combining ITV(MIP) and GTV(3D), ITV(10phase) and GTV(3D), and ITV(10phase) and ITV(COMB), respectively. All 6 volumes (GTV(3D) and ITV1 to ITV5) were delineated in the same lung window by the same radiation oncologist. The percentage of volume difference (PVD) between any 2 different volumes was determined and was correlated to effective tumor diameter (ETD), tumor motion ranges, R(3D), and the amplitude variability of the recorded breathing signal (v) to assess their volume variations.
RESULTS: The mean (range) tumor motion (R(SI), R(AP), R(ML), and R(3D)) and breathing variability (v) were 7.6 mm (2-18 mm), 4.0 mm (2-8 mm), 3.3 mm (0-7.5 mm), 9.9 mm (4.1-18.7 mm), and 0.17 (0.07-0.37), respectively. The trend of volume variation was GTV(3D) <ITV1 <ITV2 ≈ ITV3 < ITV4 < ITV5. The means ± SDs of these volumes were 11.1 ± 9.3 cc, 13.2 ± 10.5 cc, 14.9 ± 11.0 cc, 14.7 ± 11.4 cc, 15.9 ± 11.7 cc, and 16.4 ± 11.8 cc, respectively. All comparisons between the target volumes showed statistical significance (P≤.001), except for ITV2 and ITV3 (P=.594). The PVDs for all volume pairs correlated negatively with ETD (r≤-0.658, P≤.006) and positively with R(3D) (r≥0.503, P≤.047). The PVDs for pairs of ITV2 vs ITV5 and ITV5 vs ITV4 negatively correlated with ETD (r=0.502, -0.626; P=.047, .010). No other correlation was found.
CONCLUSION: Uncertainties in individualized ITVs for SBRT of early stage NSCLC could effectively be minimized by combining information from 3DCT, 4DCT, and MIP. If these images cannot be efficiently contoured, a combination of ITV(MIP) and GTV(3D) could be an effective alternative.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 22687196     DOI: 10.1016/j.ijrobp.2012.04.032

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN: 0360-3016            Impact factor:   7.038


  19 in total

Review 1.  Stereotactic body radiotherapy treatment of extracranial metastases.

Authors:  Joseph K Salama; John P Kirkpatrick; Fang-Fang Yin
Journal:  Nat Rev Clin Oncol       Date:  2012-09-25       Impact factor: 66.675

2.  Accounting for respiratory motion in small serial structures during radiotherapy planning: proof of concept in virtual bronchoscopy-guided lung functional avoidance radiotherapy.

Authors:  Esther Vicente; Arezoo Modiri; Kun-Chang Yu; Henky Wibowo; Yulong Yan; Robert Timmerman; Amit Sawant
Journal:  Phys Med Biol       Date:  2019-11-21       Impact factor: 3.609

3.  A robust deformable image registration enhancement method based on radial basis function.

Authors:  Xiao Liang; Fang-Fang Yin; Chunhao Wang; Jing Cai
Journal:  Quant Imaging Med Surg       Date:  2019-07

4.  Interfractional variations of tumor centroid position and tumor regression during stereotactic body radiotherapy for lung tumor.

Authors:  Yanan Sun; Yufei Lu; Siguo Cheng; Wei Guo; Ke Ye; Huiyun Zhao; Xiaoli Zheng; Dingjie Li; Shujuan Wang; Chengliang Yang; Hong Ge
Journal:  Biomed Res Int       Date:  2014-12-07       Impact factor: 3.411

5.  Comparison of primary target volumes delineated on four-dimensional CT and 18 F-FDG PET/CT of non-small-cell lung cancer.

Authors:  Yi-Li Duan; Jian-Bin Li; Ying-Jie Zhang; Wei Wang; Feng-Xiang Li; Xiao-Rong Sun; Yan-Luan Guo; Dong-Ping Shang
Journal:  Radiat Oncol       Date:  2014-08-15       Impact factor: 3.481

6.  Systemic Inflammation Biomarkers Predict Survival in Patients of Early Stage Non-Small Cell Lung Cancer Treated With Stereotactic Ablative Radiotherapy - A Single Center Experience.

Authors:  Hui Luo; Hong Ge; Yingying Cui; Jiangong Zhang; Ruitai Fan; Anping Zheng; Xiaoli Zheng; Yanan Sun
Journal:  J Cancer       Date:  2018-01-01       Impact factor: 4.207

7.  Reconstitution of internal target volumes by combining four-dimensional computed tomography and a modified slow computed tomography scan in stereotactic body radiotherapy planning for lung cancer.

Authors:  Seong Soon Jang; Gil Ja Huh; Suk Young Park; Po Song Yang; Hae Nam Chung; Jae Hyuk Seo; Ji Chan Park; Young Jun Yang; Eun Youn Cho
Journal:  Radiat Oncol       Date:  2014-05-02       Impact factor: 3.481

8.  To gate or not to gate - dosimetric evaluation comparing Gated vs. ITV-based methodologies in stereotactic ablative body radiotherapy (SABR) treatment of lung cancer.

Authors:  Joshua Kim; Qixue Wu; Bo Zhao; Ning Wen; Munther Ajlouni; Benjamin Movsas; Indrin J Chetty
Journal:  Radiat Oncol       Date:  2016-09-22       Impact factor: 3.481

9.  Dosimetric Analysis of Microscopic Disease in SBRT for Lung Cancers.

Authors:  Ronghu Mao; Lingling Tian; You Zhang; Lei Ren; Renqi Gao; Fang-Fang Yin; Hong Ge
Journal:  Technol Cancer Res Treat       Date:  2017-10-11

10.  Evaluation of interfractional variation of the centroid position and volume of internal target volume during stereotactic body radiotherapy of lung cancer using cone-beam computed tomography.

Authors:  Yanan Sun; Hong Ge; Siguo Cheng; Chengliang Yang; Qianqian Zhu; Dingjie Li; Yuan Tian
Journal:  J Appl Clin Med Phys       Date:  2016-03-08       Impact factor: 2.102

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.